Harleys Limited Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: Harleys Limited Pharmaceutical Import Records from India — 3 Products, $174.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Harleys Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $174.5K Trade | TransData Nexus

Harleys Limited

Pharmaceutical Importer · Kenya · Analgesics & Antipyretics Focus · $174.5K Total Trade · DGFT Verified

Harleys Limited is a pharmaceutical importer based in Kenya with a total trade value of $174.5K across 3 products in 3 therapeutic categories. Based on 28 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Harleys Limited sources from 18 verified Indian suppliers, with Ajanta Pharma Limited accounting for 32.0% of imports.

Harleys Limited — Import Portfolio & Supplier Network

Harleys Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Harleys Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ajanta Pharma Limited	$2.5M	932	32.0%
Troikaa Pharmaceuticals Limited	$2.2M	110	27.9%
Medico Remedies Limited

What Formulations Does Harleys Limited Import?

Formulation	Value	Ships
Sevotroy 250 (sevoflurane USP 250 ML)	$100.0K	2
Pharmaceuticals formulations -isotroy 250 isoflurane	$100.0K	2
Kamagra oral jelly 100MG/5GM [7	$85.8K	4
Troypofol 20 ML propofol injection BP i.	$75.3K	2
Meclox ampicillin + cloxacillin capsules 10000x10x10=10,00	$73.4K	3
Aprazole plus 20 oral suspension	$73.0K	14
Aziclar- 500 (clarithromycin tabs USP	$68.2K	2
Pharmaceuticals formulations isotroy 250 (isoflurane USP)	$65.7K	2
Erygyl erythromycin stearate tabs BP 500MG 5000x10x10=05,00	$56.2K	3
Erygyl (erythromycin stearate tabs BP	$54.8K	3
Isotroy 250 (isoflurane USP) total	$50.0K	1
Lipholyn injection 50MG (liposomal	$50.0K	1
Xykaa extend 1000 paracetamol extended	$50.0K	1
Xykaa extend 1000,paracetamol extended	$50.0K	1
Dynapar qps (diclofenac diethylamine	$50.0K	1

Harleys Limited imports 969 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fentanyl	Analgesics & Antipyretics	$113.5K	11	3.0%	5
2	Tofacitinib	Advanced Oncology	$32.1K	14	0.8%	7
3	Linagliptin	Advanced Diabetes Medications	$28.9K	3	0.7%	10

Harleys Limited imports 3 pharmaceutical products across 3 categories into Kenya totaling $174.5K.

Harleys Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Harleys Limited is a leading pharmaceutical importer and distributor based in Nairobi, Kenya. Established in 1953 as a retail chemist, the company underwent a management buy-out in 1975, focusing on the importation and distribution of pharmaceuticals, over-the-counter (OTC) products, surgical equipment, and medical devices. Over the decades, Harleys has expanded its operations across East Africa, with offices and stock points in Nairobi, Mombasa, Eldoret, Dar es Salaam, and Kampala. The company serves a diverse clientele, including hospitals, pharmacies, and healthcare professionals, and has established partnerships with global suppliers such as GSK, Abbott, Servier, Merck, and Novo Nordisk.

2Distribution Network

Harleys Limited operates a robust distribution network with strategic locations in Nairobi, Mombasa, Eldoret, Dar es Salaam, and Kampala. This extensive presence enables the company to effectively serve the East African region, ensuring timely delivery of pharmaceutical products to various healthcare facilities. The company's logistics capabilities are supported by a team of over 500 professionals, facilitating efficient supply chain management and distribution operations.

3Industry Role

In Kenya's pharmaceutical supply chain, Harleys Limited functions primarily as a pharmaceutical importer and distributor. The company imports a wide range of pharmaceutical products, including ethical medicines, OTC drugs, ophthalmic products, surgical equipment, and medical devices. By partnering with reputable global suppliers, Harleys ensures the availability of quality healthcare products across East Africa.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Harleys Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Harleys Limited's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. The company's total import value from India stands at $174,000 USD, encompassing 28 shipments and 3 products across 3 therapeutic categories. The top three imported products are Fentanyl ($113,000 USD), Tofacitinib ($32,000 USD), and Linagliptin ($29,000 USD), collectively accounting for 100% of the company's pharmaceutical imports from India. This concentrated sourcing approach may pose risks related to supply chain disruptions, currency fluctuations, and dependency on a limited number of suppliers. However, it also suggests a strategic focus on specific high-demand products.

2Supply Chain Resilience

Harleys Limited's supply chain resilience is influenced by its concentrated sourcing from India. The company imports finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, from a diverse set of 18 Indian suppliers. This diversity in suppliers may mitigate risks associated with single-source dependency. However, the company's reliance on a single country for sourcing exposes it to potential disruptions due to geopolitical issues, regulatory changes, or logistical challenges. To enhance supply chain resilience, Harleys may consider diversifying its supplier base and exploring alternative sourcing options.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Kenya, the Pharmacy and Poisons Board (PPB) serves as the primary regulatory authority overseeing the importation, distribution, and sale of pharmaceutical products. The PPB ensures that all drugs and health products meet the required safety, efficacy, and quality standards before they enter the Kenyan market. The regulatory framework governing pharmaceutical imports includes the Pharmacy and Poisons Act (Cap. 244) and the Pharmacy and Poisons (Registration of Health Products and Technologies) Rules, which outline the procedures for drug registration, importation, and compliance with Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Importers of pharmaceutical products into Kenya must obtain a product registration certificate from the Pharmacy and Poisons Board (PPB) for each drug intended for importation. This process involves submitting an application that includes detailed information about the product, its manufacturing process, and evidence of compliance with GMP standards. The PPB recognizes GMP certificates from competent regulatory authorities, such as the World Health Organization (WHO) and the European Medicines Agency (EMA), facilitating the importation of quality-assured products. Additionally, importers are required to obtain an import permit for each consignment, processed through the Kenya National TradeNet System (KESWS), ensuring compliance with national trade regulations. (infotradekenya.go.ke)

Harleys Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Harleys Limited's product strategy focuses on key therapeutic areas, including analgesics and antipyretics, advanced oncology, and advanced diabetes medications. The company's import profile indicates a significant emphasis on analgesics and antipyretics, which constitute 65.0% of its pharmaceutical imports from India. This focus aligns with the high demand for pain management and fever-reducing medications in the Kenyan market. The inclusion of advanced oncology and diabetes medications reflects a strategic approach to address the growing prevalence of chronic diseases in the region, ensuring that healthcare providers have access to essential treatments for these conditions.

2Sourcing Profile

Harleys Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India, encompassing a diverse range of products across various therapeutic categories. The company's import data reveals a concentration on specific high-demand products, such as Fentanyl, Tofacitinib, and Linagliptin, indicating a strategic focus on addressing prevalent health conditions in the region. By partnering with reputable Indian manufacturers, Harleys ensures the availability of quality-assured products that meet the regulatory standards set by the Pharmacy and Poisons Board (PPB).

3Market Positioning

Seller's Guide — How to Become a Supplier to Harleys Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Harleys Limited, given the company's focus on importing specific high-demand products. Indian exporters can explore partnerships by offering quality-assured products that align with Harleys' import profile, particularly in therapeutic areas such as oncology and diabetes medications. However, potential suppliers must ensure compliance with the Pharmacy and Poisons Board's registration requirements and maintain high manufacturing standards to meet the regulatory expectations of the Kenyan market.

2Requirements & Qualifications

Indian exporters seeking to supply Harleys Limited and the Kenyan market must obtain a Good Manufacturing Practice (GMP) certificate from a competent regulatory authority, such as the World Health Organization (WHO) or the European Medicines Agency (EMA). Additionally, they must ensure that their products are registered with the Pharmacy and Poisons Board (PPB) of Kenya, adhering to the registration procedures outlined in the Pharmacy and Poisons (Registration of Health Products and Technologies) Rules. Compliance with these requirements is essential for market access and to maintain the quality standards expected by Kenyan regulators.

How to Approach

Frequently Asked Questions — Harleys Limited

What products does Harleys Limited import from India?

Harleys Limited imports 3 pharmaceutical products across 3 categories. Top imports: Fentanyl ($113.5K), Tofacitinib ($32.1K), Linagliptin ($28.9K).

Who supplies pharmaceuticals to Harleys Limited from India?

Harleys Limited sources from 18 verified Indian suppliers. The primary supplier is Ajanta Pharma Limited (32.0% of imports, $2.5M).

What is Harleys Limited's total pharmaceutical import value?

Harleys Limited's total pharmaceutical import value from India is $174.5K, based on 28 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Harleys Limited focus on?

Harleys Limited imports across 3 categories. The largest: Analgesics & Antipyretics (65.0%), Advanced Oncology (18.4%), Advanced Diabetes Medications (16.6%).

Get Full Harleys Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.